Total Funding
68
80
Total FundingSeries C raised
Growth Score 68 in past quarter
-1 pts
Heat Score 80 in past quarter
25 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
73274
DeepQure is a medical device company developing a laparoscopic extravascular renal denervation system and exploring applications.
- Jason Jones: Global Vice President of Clinical & Regulatory AffairsPast Role: SoniVie, Global VP of Clinical Affairs
About the Company
DeepQure is a medical device startup on a mission to redefine cardiovascular disease treatment through innovation. The company is advancing Renal Denervation therapy with RDN solution for resistant hypertension. DeepQure aims to provide lasting solutions for patients who do not respond to traditional treatments. The company is also expanding its
research into other cardiovascular conditions, establishing a new standard for interventional therapy.